Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Iodine radioisotope |
Is a |
False |
iod OG/ELLER iodforbindelse |
Inferred relationship |
Some |
|
Iodide salt |
Is a |
False |
iod OG/ELLER iodforbindelse |
Inferred relationship |
Some |
|
Iodine |
Is a |
False |
iod OG/ELLER iodforbindelse |
Inferred relationship |
Some |
|
Iodoform |
Is a |
False |
iod OG/ELLER iodforbindelse |
Inferred relationship |
Some |
|
Iodic acid |
Is a |
False |
iod OG/ELLER iodforbindelse |
Inferred relationship |
Some |
|
Iodine compound |
Is a |
False |
iod OG/ELLER iodforbindelse |
Inferred relationship |
Some |
|
Periodate salt |
Is a |
False |
iod OG/ELLER iodforbindelse |
Inferred relationship |
Some |
|
jodatsalt |
Is a |
False |
iod OG/ELLER iodforbindelse |
Inferred relationship |
Some |
|
Chloriodised oil |
Is a |
False |
iod OG/ELLER iodforbindelse |
Inferred relationship |
Some |
|
Ipodate |
Is a |
False |
iod OG/ELLER iodforbindelse |
Inferred relationship |
Some |
|
Ethiodized oil |
Is a |
False |
iod OG/ELLER iodforbindelse |
Inferred relationship |
Some |
|
Iopanoic acid (substance) |
Is a |
False |
iod OG/ELLER iodforbindelse |
Inferred relationship |
Some |
|
Povidone iodine (substance) |
Is a |
False |
iod OG/ELLER iodforbindelse |
Inferred relationship |
Some |
|
iodprodukt |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
iod OG/ELLER iodforbindelse |
Inferred relationship |
Some |
|
Aqueous iodine 130mg/mL oral solution BP |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
iod OG/ELLER iodforbindelse |
Inferred relationship |
Some |
|
Iodine weak solution BP |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
iod OG/ELLER iodforbindelse |
Inferred relationship |
Some |
|
Iodine strong solution BP |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
iod OG/ELLER iodforbindelse |
Inferred relationship |
Some |
|
Product containing iodine and methyl salicylate (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
iod OG/ELLER iodforbindelse |
Inferred relationship |
Some |
|
Product containing iodine and isopropyl alcohol (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
iod OG/ELLER iodforbindelse |
Inferred relationship |
Some |
|
jod 0,7 % + isopropylalkohol 74 % w/w opløsning til topikal anvendelse |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
iod OG/ELLER iodforbindelse |
Inferred relationship |
Some |
|
diatrizoatmeglumin 600 mg + iod 282 mg/ml (60 %) injektionsvæske, opløsning, hætteglas a 50 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
iod OG/ELLER iodforbindelse |
Inferred relationship |
Some |
|
iopamidol 755 mg/ml + jod 370 mg/ml injektionsvæske, opløsning, flaske á 125 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
iod OG/ELLER iodforbindelse |
Inferred relationship |
Some |
|
iopamidol 755 mg/ml + iod 370 mg/ml injektionsvæske, opløsning, flaske a 150 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
iod OG/ELLER iodforbindelse |
Inferred relationship |
Some |
|
diatrizoatmeglumin 600 mg + iod 282 mg/ml (60 %) injektionsvæske, opløsning, hætteglas a 10 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
iod OG/ELLER iodforbindelse |
Inferred relationship |
Some |
|
diatrizoatmeglumin 300 mg + iod 141 mg/ml (30 %) injektionsvæske, opløsning, flaske a 300 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
iod OG/ELLER iodforbindelse |
Inferred relationship |
Some |
|
diatrizoatmeglumin 180 mg + iod 85 mg/ml (18 %) injektionsvæske, opløsning, flaske a 300 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
iod OG/ELLER iodforbindelse |
Inferred relationship |
Some |
|
diatrizoatmeglumin 600 mg + iod 282 mg/ml (60 %) injektionsvæske, opløsning, flaske a 2000 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
iod OG/ELLER iodforbindelse |
Inferred relationship |
Some |
|
diatrizoatmeglumin 600 mg + iod 282 mg/ml (60 %) injektionsvæske, opløsning, flaske a 1000 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
iod OG/ELLER iodforbindelse |
Inferred relationship |
Some |
|
iopamidol 755 mg/ml + iod 370 mg/ml injektionsvæske, opløsning, flaske a 100 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
iod OG/ELLER iodforbindelse |
Inferred relationship |
Some |
|
diatrizoatmeglumin 600 mg + iod 282 mg/ml (60 %) injektionsvæske, opløsning, flaske a 1500 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
iod OG/ELLER iodforbindelse |
Inferred relationship |
Some |
|
iopamidol 755 mg/ml + jod 370 mg/ml injektionsvæske, opløsning, hætteglas á 50 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
iod OG/ELLER iodforbindelse |
Inferred relationship |
Some |
|
iopamidol 755 mg/ml + iod 370 mg/ml injektionsvæske, opløsning, flaske a 200 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
iod OG/ELLER iodforbindelse |
Inferred relationship |
Some |
|
diatrizoatmeglumin 300 mg + iod 141 mg/ml (30 %) injektionsvæske, opløsning, hætteglas a 50 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
iod OG/ELLER iodforbindelse |
Inferred relationship |
Some |
|
diatrizoatmeglumin 600 mg + iod 282 mg/ml (60 %) injektionsvæske, opløsning, flaske a 1250 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
iod OG/ELLER iodforbindelse |
Inferred relationship |
Some |
|
iopamidol 755 mg/ml + iod 370 mg/ml injektionsvæske, opløsning, hætteglas a 20 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
iod OG/ELLER iodforbindelse |
Inferred relationship |
Some |
|
iopamidol 755 mg/ml + iod 370 mg/ml injektionsvæske, opløsning, flaske a 75 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
iod OG/ELLER iodforbindelse |
Inferred relationship |
Some |
|
diatrizoatmeglumin 600 mg + iod 282 mg/ml (60 %) injektionsvæske, opløsning, flaske a 150 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
iod OG/ELLER iodforbindelse |
Inferred relationship |
Some |
|
diatrizoatmeglumin 600 mg + iod 282 mg/ml (60 %) injektionsvæske, opløsning, hætteglas a 20 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
iod OG/ELLER iodforbindelse |
Inferred relationship |
Some |
|
diatrizoatmeglumin 600 mg + iod 282 mg/ml (60 %) injektionsvæske, opløsning, flaske a 200 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
iod OG/ELLER iodforbindelse |
Inferred relationship |
Some |
|
iopamidol 755 mg/ml + iod 370 mg/ml injektionsvæske, opløsning, flaske a 175 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
iod OG/ELLER iodforbindelse |
Inferred relationship |
Some |
|
diatrizoatmeglumin 600 mg + iod 282 mg/ml (60 %) injektionsvæske, opløsning, flaske a 100 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
iod OG/ELLER iodforbindelse |
Inferred relationship |
Some |
|
iopamidol 755 mg/ml + iod 370 mg/ml injektionsvæske, opløsning, hætteglas a 30 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
iod OG/ELLER iodforbindelse |
Inferred relationship |
Some |
|
Iodinated contrast media (substance) |
Is a |
False |
iod OG/ELLER iodforbindelse |
Inferred relationship |
Some |
|
Iodine compounds overdose |
Causative agent |
False |
iod OG/ELLER iodforbindelse |
Inferred relationship |
Some |
|
Iodine-induced hyperthyroidism |
Causative agent |
False |
iod OG/ELLER iodforbindelse |
Inferred relationship |
Some |
|